Corcept Therapeutics Incorporated CORT
$ 57.52
2.86%
Quarterly report 2024-Q3
added 10-30-2024
Country |
USA |
IPO year |
2004 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITALSPB |
CEO |
Dr. Joseph Belanoff |
Employees in the company |
206 |
Shares |
104 M |
Market Cap[1] |
$ 5.96 B |
EBITDA (LTM) |
$ 109 M |
P/E (LTM) |
34.23 |
P/S (LTM) |
7.87 |
EPS (LTM) |
1.37 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.